Evidence map›Paper›PMID 29099076›Full record

ArticleNanomaterials (Basel, Switzerland)2017

One-Pot Facile Methodology to Synthesize Chitosan-ZnO-Graphene Oxide Hybrid Composites for Better Dye Adsorption and Antibacterial Activity.

Anandhavelu Sanmugam, Dhanasekaran Vikraman, Hui Joon Park, Hyun-Seok Kim

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Synthesis and Antibacterial Properties of Novel ZnMnNanomaterials (Basel, Switzerland) · 2019
    Article
  12. Article
  13. Nanomaterials as Promising Alternative in the Infection Treatment.International journal of molecular sciences · 2019
    Review
  14. Effect of TiONanomaterials (Basel, Switzerland) · 2019
    Article
  15. Antibacterial Activity of Nanomaterials.Nanomaterials (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anandhavelu SanmugamDepartment of Chemistry (S&H), Vel Tech Multitech Dr.Rangarajan Dr.Sakunthala Engineering College, Chennai 600062, India. sranand2204@gmail.com.ORCID 0000-0002-7191-3056
Dhanasekaran VikramanDivision of Electronics and Electrical Engineering, Dongguk University-Seoul, Seoul 04620, Korea. v.j.dhanasekaran@gmail.com.ORCID 0000-0001-8991-3604
Hui Joon ParkDepartment of Electrical and Computer Engineering, Ajou University, Suwon 16499, Korea. huijoon@ajou.ac.kr.
Hyun-Seok KimDivision of Electronics and Electrical Engineering, Dongguk University-Seoul, Seoul 04620, Korea. hyunseokk@dongguk.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel chitosan-ZnO-graphene oxide hybrid composites were prepared using a one-pot chemical strategy, and their dye adsorption characteristics and antibacterial activity were demonstrated. The prepared chitosan and the hybrids such as chitosan-ZnO and chitosan-ZnO-graphene oxide were characterized by UV-Vis absorption spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, and transmission electron microscopy. The thermal and mechanical properties indicate a significant improvement over chitosan in the hybrid composites. Dye adsorption experiments were carried out using methylene blue and chromium complex as model pollutants with the function of dye concentration. The antibacterial properties of chitosan and the hybrids were tested against Gram-positive and Gram-negative bacterial species, which revealed minimum inhibitory concentrations (MICs) of 0.1 µg/mL.

Indexed as

antibacterial activitychitosandye adsorptionFTIRnano hybrid compositesTEM

Identifiers

PMID29099076
PMCPMC5707580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.